Results 21 to 30 of about 6,377,054 (306)
Life, 2023 Advances in the diagnosis and treatment of pulmonary hypertension (PH) have gradually improved the disease course. This retrospective cohort study aims to explore the diagnostic hemodynamic profile and survival of PH patients and their temporal changes ...
Georgios E. Papadopoulos +12 more
doaj +1 more source
The Effects of Inhaled Steroid and Theophylline on Systemic Inflammation in Copd
European Journal of Inflammation, 2011 Chronic obstructive pulmonary disease (COPD) is a systemic disease characterized by chronic, progressive airflow limitation and airway inflammation. In this study, our aim is to compare the effects of inhaled corticosteroids and theophylline on systemic ...
H. Boyaci +5 more
doaj +1 more source
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]
, 2011 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Christopher J Cates +3 more
core +1 more source
BMC Pulmonary Medicine, 2023 Backgrounds Mounting evidences have highlighted the association between metabolites and cardiovascular diseases. Our previous works have demonstrated that circulating metabolite, trimethylamine oxide, was associated with prognosis of patients with ...
Yicheng Yang +8 more
doaj +1 more source
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review [PDF]
, 2009 Exacerbations of chronic obstructive pulmonary disease (COPD) are important events in the natural history of this prevalent and devastating condition. This review provides a concise, state of the art summary on prevention and management of exacerbations.
Hurst, JR +5 more
core +2 more sources
Relationship between ID1 and EGFR-TKI Resistance in Non-small Cell Lung Cancer
Chinese Journal of Lung Cancer, 2016 Background and objective Non-small cell lung cancer (NSCLC) presents the highest morbidity and mortality among malignant tumors worldwide. The overall effective rate of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is 30% to 40 ...
Yuchen BAO +7 more
doaj +1 more source
ESC Heart Failure, 2023 Intravenous (i.v.) prostacyclin is the cornerstone treatment in high‐risk pulmonary arterial hypertension (PAH) patients. Selexipag is an orally available prostacyclin receptor agonist.
André Alexandre +7 more
doaj +1 more source
Progress in the Metabolomics of Acute Coronary Syndrome
Reviews in Cardiovascular Medicine, 2023 Acute coronary syndrome (ACS) is a severe type of coronary heart disease (CHD) with increasing prevalence and significant challenges for prevention and treatment.
Fu Zhang +7 more
doaj +1 more source
Comparative Study on the Quality of Life of Chronic Obstructive Pulmonary Disease Patients [PDF]
Objective: The main goal of this study is to compare the Quality of Life (QoL) of Chronic Obstructive Pulmonary Disease (COPD) patients between three different regions: the United Arab Emirates (UAE), the United Kingdom (UK) and Morocco. Another aim of
Bihi, Imane Ben
core +6 more sources
Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer [PDF]
, 2011 Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome.
Derek Grose MRCP, FRCR +3 more
core +1 more source